| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | superoxide-generating NADPH oxidase activator activity | 7.28e-06 | 10 | 80 | 3 | GO:0016176 | |
| GeneOntologyMolecularFunction | superoxide-generating NAD(P)H oxidase activity | 1.33e-05 | 12 | 80 | 3 | GO:0016175 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor | 6.72e-05 | 20 | 80 | 3 | GO:0050664 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4-bisphosphate binding | 3.70e-04 | 35 | 80 | 3 | GO:0043325 | |
| GeneOntologyBiologicalProcess | embryonic skeletal system development | 9.86e-08 | 148 | 79 | 8 | GO:0048706 | |
| GeneOntologyBiologicalProcess | anterior/posterior pattern specification | 4.34e-07 | 247 | 79 | 9 | GO:0009952 | |
| GeneOntologyBiologicalProcess | neutrophil-mediated killing of gram-positive bacterium | 5.38e-07 | 5 | 79 | 3 | GO:0070946 | |
| GeneOntologyBiologicalProcess | NADP catabolic process | 1.87e-06 | 7 | 79 | 3 | GO:0006742 | |
| GeneOntologyBiologicalProcess | neutrophil-mediated killing of fungus | 1.87e-06 | 7 | 79 | 3 | GO:0070947 | |
| GeneOntologyBiologicalProcess | regulation of respiratory burst involved in inflammatory response | 8.73e-06 | 11 | 79 | 3 | GO:0060264 | |
| GeneOntologyBiologicalProcess | respiratory burst involved in inflammatory response | 1.50e-05 | 13 | 79 | 3 | GO:0002536 | |
| GeneOntologyBiologicalProcess | neutrophil-mediated killing of bacterium | 2.92e-05 | 16 | 79 | 3 | GO:0070944 | |
| GeneOntologyBiologicalProcess | neutrophil mediated immunity | 3.41e-05 | 48 | 79 | 4 | GO:0002446 | |
| GeneOntologyBiologicalProcess | response to yeast | 4.23e-05 | 18 | 79 | 3 | GO:0001878 | |
| GeneOntologyBiologicalProcess | neutrophil-mediated killing of symbiont cell | 5.01e-05 | 19 | 79 | 3 | GO:0070943 | |
| GeneOntologyBiologicalProcess | respiratory burst involved in defense response | 5.88e-05 | 20 | 79 | 3 | GO:0002679 | |
| GeneOntologyBiologicalProcess | embryonic skeletal system morphogenesis | 6.21e-05 | 109 | 79 | 5 | GO:0048704 | |
| GeneOntologyBiologicalProcess | neutrophil mediated cytotoxicity | 6.84e-05 | 21 | 79 | 3 | GO:0070942 | |
| GeneOntologyBiologicalProcess | negative regulation of smooth muscle contraction | 7.90e-05 | 22 | 79 | 3 | GO:0045986 | |
| GeneOntologyBiologicalProcess | hydrogen peroxide biosynthetic process | 7.90e-05 | 22 | 79 | 3 | GO:0050665 | |
| GeneOntologyBiologicalProcess | regionalization | 8.74e-05 | 478 | 79 | 9 | GO:0003002 | |
| GeneOntologyBiologicalProcess | regulation of respiratory burst | 9.06e-05 | 23 | 79 | 3 | GO:0060263 | |
| GeneOntologyBiologicalProcess | skeletal system development | 1.17e-04 | 615 | 79 | 10 | GO:0001501 | |
| GeneOntologyBiologicalProcess | defense response to fungus | 1.59e-04 | 71 | 79 | 4 | GO:0050832 | |
| GeneOntologyBiologicalProcess | pattern specification process | 1.80e-04 | 526 | 79 | 9 | GO:0007389 | |
| GeneOntologyBiologicalProcess | response to fungus | 3.19e-04 | 85 | 79 | 4 | GO:0009620 | |
| GeneOntologyBiologicalProcess | negative regulation of muscle contraction | 3.24e-04 | 35 | 79 | 3 | GO:0045932 | |
| GeneOntologyBiologicalProcess | positive regulation of mesenchymal cell proliferation | 3.52e-04 | 36 | 79 | 3 | GO:0002053 | |
| GeneOntologyBiologicalProcess | negative regulation of monocyte differentiation | 4.00e-04 | 8 | 79 | 2 | GO:0045656 | |
| GeneOntologyBiologicalProcess | killing by host of symbiont cells | 4.14e-04 | 38 | 79 | 3 | GO:0051873 | |
| GeneOntologyBiologicalProcess | leukotriene metabolic process | 5.19e-04 | 41 | 79 | 3 | GO:0006691 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | NKX2-8 ARHGEF40 ANK3 SYNE1 DRGX FGD1 SPAG9 MARK2 PARD3 PHIP DCLK1 STRIP1 TRAK1 | 5.71e-04 | 1194 | 79 | 13 | GO:0000902 |
| GeneOntologyBiologicalProcess | respiratory burst | 5.98e-04 | 43 | 79 | 3 | GO:0045730 | |
| GeneOntologyBiologicalProcess | skeletal system morphogenesis | 6.80e-04 | 277 | 79 | 6 | GO:0048705 | |
| GeneOntologyBiologicalProcess | regulation of mesenchymal cell proliferation | 6.83e-04 | 45 | 79 | 3 | GO:0010464 | |
| GeneOntologyCellularComponent | NADPH oxidase complex | 4.23e-05 | 18 | 80 | 3 | GO:0043020 | |
| MousePheno | increased angiotensin I-converting enzyme activity | 1.65e-06 | 6 | 62 | 3 | MP:0003184 | |
| MousePheno | abnormal angiotensin I-converting enzyme activity | 1.65e-06 | 6 | 62 | 3 | MP:0013254 | |
| MousePheno | decreased vasoconstriction | 2.42e-06 | 22 | 62 | 4 | MP:0003026 | |
| MousePheno | abnormal vasoconstriction | 2.65e-06 | 50 | 62 | 5 | MP:0000250 | |
| MousePheno | liver abscess | 2.87e-06 | 7 | 62 | 3 | MP:0003332 | |
| MousePheno | abnormal circulating renin level | 7.67e-06 | 29 | 62 | 4 | MP:0003349 | |
| MousePheno | impaired granulocyte bactericidal activity | 9.75e-06 | 10 | 62 | 3 | MP:0005074 | |
| MousePheno | impaired smooth muscle contractility | 1.66e-05 | 35 | 62 | 4 | MP:0000740 | |
| MousePheno | abnormal bronchus epithelium morphology | 1.78e-05 | 12 | 62 | 3 | MP:0010943 | |
| MousePheno | trachea occlusion | 1.94e-05 | 2 | 62 | 2 | MP:0013497 | |
| MousePheno | cervical vertebral transformation | 3.14e-05 | 41 | 62 | 4 | MP:0004615 | |
| MousePheno | increased rib number | 3.80e-05 | 43 | 62 | 4 | MP:0000480 | |
| MousePheno | increased heart atrium size | 4.98e-05 | 46 | 62 | 4 | MP:0008725 | |
| MousePheno | decreased susceptibility to Orthomyxoviridae infection | 6.47e-05 | 18 | 62 | 3 | MP:0020947 | |
| MousePheno | abnormal heart atrium size | 9.40e-05 | 54 | 62 | 4 | MP:0031576 | |
| MousePheno | vertebral transformation | 1.25e-04 | 110 | 62 | 5 | MP:0003036 | |
| MousePheno | increased circulating renin level | 1.38e-04 | 23 | 62 | 3 | MP:0003352 | |
| MousePheno | single kidney | 1.52e-04 | 61 | 62 | 4 | MP:0003604 | |
| MousePheno | abnormal cervical vertebrae morphology | 1.88e-04 | 120 | 62 | 5 | MP:0003048 | |
| MousePheno | abnormal intestinal goblet cell morphology | 2.06e-04 | 66 | 62 | 4 | MP:0003449 | |
| MousePheno | abnormal vascular smooth muscle physiology | 3.84e-04 | 140 | 62 | 5 | MP:0005595 | |
| MousePheno | abnormal bronchus morphology | 4.12e-04 | 33 | 62 | 3 | MP:0002264 | |
| MousePheno | granulomatous inflammation | 5.34e-04 | 36 | 62 | 3 | MP:0002500 | |
| MousePheno | asymmetric rib joints | 6.78e-04 | 39 | 62 | 3 | MP:0000155 | |
| Domain | Homeobox_antennapedia | 1.31e-14 | 12 | 78 | 7 | IPR017995 | |
| Domain | Homeobox_Antennapedia_CS | 1.87e-12 | 21 | 78 | 7 | IPR001827 | |
| Domain | ANTENNAPEDIA | 5.50e-12 | 24 | 78 | 7 | PS00032 | |
| Domain | Homeobox_metazoa | 3.77e-09 | 90 | 78 | 8 | IPR020479 | |
| Domain | Homeobox_CS | 5.27e-09 | 186 | 78 | 10 | IPR017970 | |
| Domain | - | HOXA4 HOXA5 HOXA6 HOXA7 NCOR2 HOXB5 NKX2-8 HOXC5 HOXD4 DRGX PBX1 | 2.52e-08 | 283 | 78 | 11 | 1.10.10.60 |
| Domain | Homeobox | 4.70e-08 | 234 | 78 | 10 | PF00046 | |
| Domain | HOMEOBOX_1 | 5.09e-08 | 236 | 78 | 10 | PS00027 | |
| Domain | HOX | 5.30e-08 | 237 | 78 | 10 | SM00389 | |
| Domain | HOMEOBOX_2 | 5.73e-08 | 239 | 78 | 10 | PS50071 | |
| Domain | Homeobox_dom | 5.73e-08 | 239 | 78 | 10 | IPR001356 | |
| Domain | Homeodomain-like | HOXA4 HOXA5 HOXA6 HOXA7 NCOR2 HOXB5 NKX2-8 HOXC5 HOXD4 DRGX PBX1 | 1.28e-07 | 332 | 78 | 11 | IPR009057 |
| Domain | Tscrpt_reg_Myc_N | 1.03e-04 | 4 | 78 | 2 | IPR012682 | |
| Domain | Tscrpt_reg_Myc | 1.03e-04 | 4 | 78 | 2 | IPR002418 | |
| Domain | Myc_N | 1.03e-04 | 4 | 78 | 2 | PF01056 | |
| Domain | tRNA-bd_arm | 4.48e-03 | 24 | 78 | 2 | IPR010978 | |
| Pathway | REACTOME_CROSS_PRESENTATION_OF_PARTICULATE_EXOGENOUS_ANTIGENS_PHAGOSOMES | 4.39e-06 | 9 | 54 | 3 | MM14524 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES | 1.15e-04 | 25 | 54 | 3 | MM15269 | |
| Pathway | BIOCARTA_FMLP_PATHWAY | 2.92e-04 | 34 | 54 | 3 | MM1399 | |
| Pathway | REACTOME_DETOXIFICATION_OF_REACTIVE_OXYGEN_SPECIES | 3.19e-04 | 35 | 54 | 3 | MM14944 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 3.68e-04 | 161 | 54 | 5 | M27871 | |
| Pathway | REACTOME_CROSS_PRESENTATION_OF_PARTICULATE_EXOGENOUS_ANTIGENS_PHAGOSOMES | 3.97e-04 | 8 | 54 | 2 | M26926 | |
| Pathway | REACTOME_ROS_AND_RNS_PRODUCTION_IN_PHAGOCYTES | 4.08e-04 | 38 | 54 | 3 | MM14519 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 4.54e-04 | 94 | 54 | 4 | M1041 | |
| Pubmed | Region-specific gastrointestinal Hox code during murine embryonal gut development. | 1.10e-14 | 9 | 81 | 6 | 11869294 | |
| Pubmed | The mouse PcG gene eed is required for Hox gene repression and extraembryonic development. | 2.16e-14 | 20 | 81 | 7 | 12370779 | |
| Pubmed | 4.72e-14 | 22 | 81 | 7 | 2576652 | ||
| Pubmed | 9.55e-14 | 24 | 81 | 7 | 9367423 | ||
| Pubmed | The Polycomb-group homolog Bmi-1 is a regulator of murine Hox gene expression. | 2.24e-13 | 13 | 81 | 6 | 8887324 | |
| Pubmed | 3.91e-13 | 14 | 81 | 6 | 1348361 | ||
| Pubmed | 3.37e-12 | 8 | 81 | 5 | 1976088 | ||
| Pubmed | Hox genes regulate the onset of Tbx5 expression in the forelimb. | 3.37e-12 | 8 | 81 | 5 | 22872086 | |
| Pubmed | 3.39e-12 | 38 | 81 | 7 | 15042701 | ||
| Pubmed | 3.39e-12 | 38 | 81 | 7 | 11857506 | ||
| Pubmed | 4.13e-12 | 39 | 81 | 7 | 33257809 | ||
| Pubmed | Quantification of Hox and surfactant protein-B transcription during murine lung development. | 4.99e-12 | 40 | 81 | 7 | 19204410 | |
| Pubmed | 6.01e-12 | 41 | 81 | 7 | 32479258 | ||
| Pubmed | Crypto-rhombomeres of the mouse medulla oblongata, defined by molecular and morphological features. | 6.97e-12 | 21 | 81 | 6 | 25381007 | |
| Pubmed | Altered cellular proliferation and mesoderm patterning in Polycomb-M33-deficient mice. | 7.56e-12 | 9 | 81 | 5 | 9043087 | |
| Pubmed | Coordinated expression of 3' hox genes during murine embryonal gut development: an enteric Hox code. | 7.56e-12 | 9 | 81 | 5 | 10579975 | |
| Pubmed | 8.59e-12 | 43 | 81 | 7 | 22701719 | ||
| Pubmed | 1.02e-11 | 44 | 81 | 7 | 1973146 | ||
| Pubmed | 1.66e-11 | 47 | 81 | 7 | 1358459 | ||
| Pubmed | New insights into the role of Jmjd3 and Utx in axial skeletal formation in mice. | 2.63e-11 | 50 | 81 | 7 | 28188179 | |
| Pubmed | Expression of a homeo domain protein in noncontact-inhibited cultured cells and postmitotic neurons. | 2.73e-11 | 4 | 81 | 4 | 2890554 | |
| Pubmed | 2.93e-11 | 26 | 81 | 6 | 8646877 | ||
| Pubmed | 7.67e-11 | 13 | 81 | 5 | 8625838 | ||
| Pubmed | Sf3b4 regulates chromatin remodeler splicing and Hox expression. | 1.14e-10 | 32 | 81 | 6 | 37167859 | |
| Pubmed | 1.19e-10 | 14 | 81 | 5 | 8099712 | ||
| Pubmed | 3.61e-10 | 118 | 81 | 8 | 16971476 | ||
| Pubmed | 9.50e-10 | 7 | 81 | 4 | 7680626 | ||
| Pubmed | 9.50e-10 | 7 | 81 | 4 | 23200858 | ||
| Pubmed | Corepressor SMRT is required to maintain Hox transcriptional memory during somitogenesis. | 1.19e-09 | 21 | 81 | 5 | 30254164 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 1.16e-08 | 358 | 81 | 10 | 32460013 | |
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 18036262 | ||
| Pubmed | Transient loss of resistance to pulmonary tuberculosis in p47(phox-/-) mice. | 1.22e-08 | 3 | 81 | 3 | 10678931 | |
| Pubmed | Colitis susceptibility in p47(phox-/-) mice is mediated by the microbiome. | 1.22e-08 | 3 | 81 | 3 | 27044504 | |
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 17167081 | ||
| Pubmed | Mice lacking NCF1 exhibit reduced growth of implanted melanoma and carcinoma tumors. | 1.22e-08 | 3 | 81 | 3 | 24358335 | |
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 10891396 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 25474113 | ||
| Pubmed | NADPH oxidase in bone marrow-derived cells mediates pulmonary ischemia-reperfusion injury. | 1.22e-08 | 3 | 81 | 3 | 18787174 | |
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 26209274 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 24873968 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 22184329 | ||
| Pubmed | NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease. | 1.22e-08 | 3 | 81 | 3 | 11018074 | |
| Pubmed | Natural Loss-of-Function Mutations in Qa2 and NCF1 Cause the Spread of Mannan-Induced Psoriasis. | 1.22e-08 | 3 | 81 | 3 | 33545139 | |
| Pubmed | Small-molecule screen identifies reactive oxygen species as key regulators of neutrophil chemotaxis. | 1.22e-08 | 3 | 81 | 3 | 20142487 | |
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 9116268 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 20686129 | ||
| Pubmed | Angiotensin II induced catabolic effect and muscle atrophy are redox dependent. | 1.22e-08 | 3 | 81 | 3 | 21570954 | |
| Pubmed | p47(phox) contributes to albuminuria and kidney fibrosis in mice. | 1.22e-08 | 3 | 81 | 3 | 25565313 | |
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 39357591 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 12958309 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 11435342 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 31118934 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 23482812 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 16041040 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 10085000 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 10987289 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 21435178 | ||
| Pubmed | Intermittent hypoxia has organ-specific effects on oxidative stress. | 1.22e-08 | 3 | 81 | 3 | 18703411 | |
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 29228045 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 17307863 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 22155727 | ||
| Pubmed | Ncf1 affects osteoclast formation but is not critical for postmenopausal bone loss. | 1.22e-08 | 3 | 81 | 3 | 27829407 | |
| Pubmed | Mechanism of endoplasmic reticulum stress-induced vascular endothelial dysfunction. | 1.22e-08 | 3 | 81 | 3 | 24576409 | |
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 22376231 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 23918780 | ||
| Pubmed | NADPH oxidase NOX2 mediates TLR2/6-dependent release of GM-CSF from endothelial cells. | 1.22e-08 | 3 | 81 | 3 | 28274989 | |
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 26645958 | ||
| Pubmed | Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. | 1.22e-08 | 3 | 81 | 3 | 12364355 | |
| Pubmed | NADPH oxidase promotes neutrophil extracellular trap formation in pulmonary aspergillosis. | 1.22e-08 | 3 | 81 | 3 | 24549323 | |
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 34557202 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 28467721 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 10670582 | ||
| Pubmed | NADPH oxidase deficiency regulates Th lineage commitment and modulates autoimmunity. | 1.22e-08 | 3 | 81 | 3 | 20881184 | |
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 26528554 | ||
| Pubmed | The role of reactive oxygen species in immunopathogenesis of rheumatoid arthritis. | 1.22e-08 | 3 | 81 | 3 | 19052348 | |
| Pubmed | Effect of early particulate air pollution exposure on obesity in mice: role of p47phox. | 1.22e-08 | 3 | 81 | 3 | 20864666 | |
| Pubmed | Reactive oxygen species delay control of lymphocytic choriomeningitis virus. | 1.22e-08 | 3 | 81 | 3 | 23328631 | |
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 34572995 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 17114280 | ||
| Pubmed | Participation of mitochondrial respiratory complex III in neutrophil activation and lung injury. | 1.22e-08 | 3 | 81 | 3 | 19168575 | |
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 25989352 | ||
| Pubmed | NADPH oxidase is the primary source of superoxide induced by NMDA receptor activation. | 1.22e-08 | 3 | 81 | 3 | 19503084 | |
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 17404617 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 17332431 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 36592568 | ||
| Pubmed | Genetic requirement of p47phox for superoxide production by murine microglia. | 1.22e-08 | 3 | 81 | 3 | 11156938 | |
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 30504842 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 10772875 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 27798190 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 20702812 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 33705493 | ||
| Pubmed | Inhibition of NADPH oxidase by apocynin attenuates progression of atherosclerosis. | 1.22e-08 | 3 | 81 | 3 | 23965970 | |
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 26455429 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 15513930 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 15626477 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 15033459 | ||
| Pubmed | NCF1 gene and pseudogene pattern: association with parasitic infection and autoimmunity. | 1.22e-08 | 3 | 81 | 3 | 19077231 | |
| Pubmed | Neutrophil-derived ROS contribute to oxidative DNA damage induction by quartz particles. | 1.22e-08 | 3 | 81 | 3 | 20828610 | |
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 20817944 | ||
| Pubmed | 1.22e-08 | 3 | 81 | 3 | 22319452 | ||
| Interaction | PBX1 interactions | 9.48e-07 | 85 | 78 | 6 | int:PBX1 | |
| Cytoband | 7p15.2 | 1.05e-06 | 43 | 81 | 4 | 7p15.2 | |
| Cytoband | 14q24.3 | 2.33e-05 | 93 | 81 | 4 | 14q24.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q24 | 2.92e-05 | 200 | 81 | 5 | chr14q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7p15 | 3.22e-05 | 101 | 81 | 4 | chr7p15 | |
| Cytoband | 7q11.23 | 6.92e-04 | 97 | 81 | 3 | 7q11.23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q11 | 1.38e-03 | 271 | 81 | 4 | chr7q11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q25 | 3.11e-03 | 164 | 81 | 3 | chr6q25 | |
| Cytoband | 9q34.11 | 4.00e-03 | 53 | 81 | 2 | 9q34.11 | |
| GeneFamily | HOXL subclass homeoboxes | 1.49e-10 | 52 | 53 | 7 | 518 | |
| Coexpression | NIKOLSKY_BREAST_CANCER_7P15_AMPLICON | 2.75e-08 | 11 | 81 | 4 | M18241 | |
| Coexpression | MULLIGHAN_NPM1_SIGNATURE_3_UP | 9.51e-07 | 335 | 81 | 9 | M10277 | |
| Coexpression | MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP | 1.67e-06 | 265 | 81 | 8 | M19170 | |
| Coexpression | VERHAAK_AML_WITH_NPM1_MUTATED_UP | 1.87e-06 | 187 | 81 | 7 | M4861 | |
| Coexpression | MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP | 5.26e-05 | 130 | 81 | 5 | M6590 | |
| Coexpression | GAVIN_PDE3B_TARGETS | 6.23e-05 | 25 | 81 | 3 | MM726 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_500 | 8.62e-06 | 194 | 80 | 7 | gudmap_kidney_P0_CapMes_Crym_k2_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#1_top-relative-expression-ranked_500 | 1.87e-05 | 42 | 80 | 4 | gudmap_developingGonad_e11.5_testes_k1_500 | |
| CoexpressionAtlas | gudmap_RNAseq_p2_CD2APMEISWT_2500_K2 | 3.63e-05 | 99 | 80 | 5 | gudmap_RNAseq_p2_CD2APMEISWT_2500_K2 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#2_top-relative-expression-ranked_200 | 5.61e-05 | 20 | 80 | 3 | gudmap_developingGonad_e11.5_testes_k2_200 | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_500 | 9.76e-05 | 196 | 80 | 6 | gudmap_kidney_P1_CapMes_Crym_k4_500 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 1.02e-04 | 123 | 80 | 5 | gudmap_kidney_P3_CapMes_Crym_k3_500 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 1.15e-04 | 202 | 80 | 6 | gudmap_kidney_P2_CapMes_Crym_k3_500 | |
| CoexpressionAtlas | Embryoid Body Cells-reprogram_OSKM-L_vs_Embryoid Body Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 1.19e-04 | 293 | 80 | 7 | PCBC_ratio_EB_from-OSKM-L_vs_EB_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Embryoid Body Cells-method_mRNA_vs_Embryoid Body Cells-method_NA-Confounder_removed-fold2.0_adjp0.05 | 1.19e-04 | 293 | 80 | 7 | PCBC_ratio_EB_from-mRNA_vs_EB_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Mesangium_2500_K0 | 1.20e-04 | 67 | 80 | 4 | gudmap_RNAseq_e15.5_Mesangium_2500_K0 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_top-relative-expression-ranked_500 | 1.22e-04 | 294 | 80 | 7 | gudmap_kidney_P0_CapMes_Crym_500 | |
| CoexpressionAtlas | PP_HSC_top-relative-expression-ranked_500_k-means-cluster#5 | 1.39e-04 | 209 | 80 | 6 | PP_HSC_500_K5 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_top-relative-expression-ranked_1000 | 1.40e-04 | 639 | 80 | 10 | gudmap_kidney_P0_CapMes_Crym_1000 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_500_k-means-cluster#2 | 2.16e-04 | 78 | 80 | 4 | ratio_EB_vs_SC_500_K2 | |
| CoexpressionAtlas | gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K2 | 2.55e-04 | 441 | 80 | 8 | gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K2 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.68e-04 | 236 | 80 | 6 | gudmap_kidney_P3_CapMes_Crym_k1_1000 | |
| ToppCell | Healthy_donor-HSPC|World / disease group, cell group and cell class (v2) | 2.36e-08 | 167 | 81 | 7 | 70630ebdfee8171d625811844f8a7c94736d101e | |
| ToppCell | Healthy_donor-HSPC|Healthy_donor / disease group, cell group and cell class (v2) | 2.89e-08 | 172 | 81 | 7 | bc7549faadfc92c683c0e26bea380458706774b5 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-MEP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.11e-08 | 181 | 81 | 7 | ee207ea171e2ffc22a7f850be57bb118a87e0f81 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_Invariant-Inducer-like-ILC3|bone_marrow / Manually curated celltypes from each tissue | 3.98e-07 | 155 | 81 | 6 | 83430a64c2cb5ad29caa3dacba76c28dd204ac40 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-ILC3|GI_small-bowel / Manually curated celltypes from each tissue | 5.95e-07 | 166 | 81 | 6 | 773673a5d0430640439845b264740bfbbdad0cb2 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like|GI_small-bowel / Manually curated celltypes from each tissue | 6.16e-07 | 167 | 81 | 6 | 3ae46c6363da76c8e1f5579e6027bf88ed637a44 | |
| ToppCell | severe_COVID-19-HSPC|severe_COVID-19 / disease group, cell group and cell class (v2) | 7.83e-07 | 174 | 81 | 6 | 6d35bacf073537b272ff821e604c899fb9ce6a7c | |
| ToppCell | severe_COVID-19-HSPC|World / disease group, cell group and cell class (v2) | 8.65e-07 | 177 | 81 | 6 | 289f6aed6f054b04b01659434d8c8b467d1bf5dd | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 1.48e-06 | 194 | 81 | 6 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 1.52e-06 | 195 | 81 | 6 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 1.52e-06 | 195 | 81 | 6 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-HSC/MPP_and_pro-MEMP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.86e-06 | 153 | 81 | 5 | 14753baa9980f75206fefc3c8b43685fd4178a43 | |
| ToppCell | Multiple_Sclerosis-Other-HSPC|Multiple_Sclerosis / Disease, Lineage and Cell Type | 1.24e-05 | 164 | 81 | 5 | 6af5529507d695b347adee4be5ead70f56c9cf55 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.47e-05 | 170 | 81 | 5 | f0b0d2d0402de3ed7322284a599646db43475761 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.47e-05 | 170 | 81 | 5 | 054360a3b05f5e41221c98b122d241b1affad26a | |
| ToppCell | 368C-Myeloid-Macrophage-FABP4+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.52e-05 | 171 | 81 | 5 | e59afa0a773dca3b9c208d17510ea55703b42598 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-CMP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.56e-05 | 172 | 81 | 5 | f18d9f061df3da96e389616abd5edfc269d3adeb | |
| ToppCell | 10x5'-blood-Mast-Mast_cells|blood / Manually curated celltypes from each tissue | 1.65e-05 | 174 | 81 | 5 | a5838821bba2be790d32331ff529d466e9974268 | |
| ToppCell | 10x5'-blood-Mast|blood / Manually curated celltypes from each tissue | 1.65e-05 | 174 | 81 | 5 | 3a8a253213b207e3ff56f94a74996b8d9ad47aa1 | |
| ToppCell | Healthy_Control-Myeloid-Mast|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.70e-05 | 175 | 81 | 5 | ca187074adcc9b8bd0fa270e2ede1564c8e6c6cf | |
| ToppCell | Healthy_Control-Myeloid-Mast-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.70e-05 | 175 | 81 | 5 | eadbbcdf2aef4cee268bc70a7a2c4175d898953b | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-HSC/MPP_and_pro-MEP|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.84e-05 | 178 | 81 | 5 | b8c301d65c0f37941e8e9414d55e90edb6ecc195 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.84e-05 | 178 | 81 | 5 | 0fb36679cddc9ed8f4b5b34e174d5133c2ea1c76 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.84e-05 | 178 | 81 | 5 | a0ab20c588e7d43d0320d4779d9ab95c1c86e297 | |
| ToppCell | COVID-19_Mild-Hematopoietic_SC-HSPC|COVID-19_Mild / Disease group, lineage and cell class | 1.89e-05 | 179 | 81 | 5 | 19fcf48f5e02e4cb2b328efb4502f337e1282f72 | |
| ToppCell | severe-Others-CD34+_GATA2+_cells|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.89e-05 | 179 | 81 | 5 | dd789a1b7327d6f9ed5272f3eb54bd43f7ae8d78 | |
| ToppCell | COVID-19_Mild-Hematopoietic_SC|COVID-19_Mild / Disease group, lineage and cell class | 1.89e-05 | 179 | 81 | 5 | 50a073166e34bcfa52a62c4dafb3aef724e0fa8e | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.05e-05 | 182 | 81 | 5 | 6497eeafb2b137e70261ec0314782831892a940d | |
| ToppCell | Control-Hematopoietic_SC-HSPC|Control / Disease group, lineage and cell class | 2.05e-05 | 182 | 81 | 5 | 14e347c0e6444410f1948851407bb18c706569f4 | |
| ToppCell | Control-Hematopoietic_SC|Control / Disease group, lineage and cell class | 2.05e-05 | 182 | 81 | 5 | 43243c6bae2ac7fa3fd1f193a17f61ee4d938ea9 | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.05e-05 | 182 | 81 | 5 | d0ebf2f0d5370458ab81485a0017c311077133d5 | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.05e-05 | 182 | 81 | 5 | bd1626261803324084fafca2f6665b50854e7fae | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.05e-05 | 182 | 81 | 5 | 2a6d1246bfb5899a0861c7f2f8fb9b43b0df8acc | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.05e-05 | 182 | 81 | 5 | 918286422b3eab32d962b49aa07b1b9512e51d9d | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.05e-05 | 182 | 81 | 5 | 0d9b8c900da8cbae9cde72aecd4026b1ac2bbd67 | |
| ToppCell | COVID-19_Severe-Hematopoietic_SC-HSPC|COVID-19_Severe / Disease group, lineage and cell class | 2.10e-05 | 183 | 81 | 5 | 4146b1c0e5f76d25226745abfa28f77127a444fc | |
| ToppCell | COVID-19_Severe-Hematopoietic_SC|COVID-19_Severe / Disease group, lineage and cell class | 2.10e-05 | 183 | 81 | 5 | 92aab7ce65aca17988bc2add4ff9fb8384e2c21b | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.16e-05 | 184 | 81 | 5 | a6169613c6493b947a176493f542368bfa935dab | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC-HSPC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.16e-05 | 184 | 81 | 5 | 51d0447699e3b8f01abbde83f26b748bc9f3c723 | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC-HSPC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.16e-05 | 184 | 81 | 5 | f7b0bb45a9055ab34e98b251217f6ec38c75ca22 | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC-HSPC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.16e-05 | 184 | 81 | 5 | cc01c19180861f491a8dc16d60fabd1215fc4525 | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC-HSPC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.16e-05 | 184 | 81 | 5 | 492c680f0769ba4e651d09c2e8e5d5d271ed08aa | |
| ToppCell | PBMC-Severe-Hematopoietic-HSPC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.16e-05 | 184 | 81 | 5 | 26edbf84216538b80f1ffcc079ee6e385a71fbf9 | |
| ToppCell | (8)_CD34_progenitor|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.27e-05 | 186 | 81 | 5 | 943c604a7cd873faf510096d094100512ba2d6bc | |
| ToppCell | (8)_CD34_progenitor|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.27e-05 | 186 | 81 | 5 | e69a986b8618effd61875fda528a2e44aab11868 | |
| ToppCell | Healthy-HSPC|World / disease group, cell group and cell class | 2.33e-05 | 187 | 81 | 5 | 8cd9e5499e5c2b2321ecbcf780df37fe0f165ac9 | |
| ToppCell | E12.5-Mesenchymal|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.39e-05 | 188 | 81 | 5 | 9778dadc2bd7ded3a723e717d1c8cd3160e99c6c | |
| ToppCell | COVID-19_Severe-HSPC|World / disease group, cell group and cell class | 2.45e-05 | 189 | 81 | 5 | 555c0b13f1508b9e3712b36d77144e73e828bc76 | |
| ToppCell | hematopoetic_progenitors-CD34+_HSC|World / Lineage and Cell class | 2.45e-05 | 189 | 81 | 5 | 51ff31c9cf5eff98ad01c0455dc4ae4908713575 | |
| ToppCell | Healthy-HSPC|Healthy / disease group, cell group and cell class | 2.45e-05 | 189 | 81 | 5 | 214b225effc40ca1b83dd8052f2a7b80b65d4938 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 2.58e-05 | 191 | 81 | 5 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | Megakaryocytic-erythropoietic-MEP|World / Lineage, cell class and subclass | 2.58e-05 | 191 | 81 | 5 | 91bbc9d3a9ecc49262060faeb0047764828c1960 | |
| ToppCell | ILEUM-non-inflamed-(6)_ILC3|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.58e-05 | 191 | 81 | 5 | 6eaf72b41084404bee0db04e4605db745a74995f | |
| ToppCell | Megakaryocytic-erythropoietic-MEP-MEP|World / Lineage, cell class and subclass | 2.58e-05 | 191 | 81 | 5 | b71dc4e27a22955926547493fc959afc20208566 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3|lymph-node_spleen / Manually curated celltypes from each tissue | 2.65e-05 | 192 | 81 | 5 | e16035b3328f9b1b2e28d234c62ba88387540550 | |
| ToppCell | E15.5-Mesenchymal|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.71e-05 | 193 | 81 | 5 | 22a9f5b61f197757f72840b9cb849cdb20430e72 | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.71e-05 | 193 | 81 | 5 | b637e1c47a98009e7d19a6daac78f888fd12748f | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 2.78e-05 | 194 | 81 | 5 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | ILEUM-inflamed-(6)_ILC|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.78e-05 | 194 | 81 | 5 | 4d51d49366c34ff1241770b4acc0167a43b3155a | |
| ToppCell | Control-Multiplet|Control / Disease state, Lineage and Cell class | 2.85e-05 | 195 | 81 | 5 | 618900c80bea09d46dad3f741bd1bff8bf0a64ee | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 2.85e-05 | 195 | 81 | 5 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-05 | 195 | 81 | 5 | 79a6e8e6de040ff07539e8901fc407363a50e355 | |
| ToppCell | Control-Multiplet-Multiplet|Control / Disease state, Lineage and Cell class | 2.85e-05 | 195 | 81 | 5 | 06ac685855e14e4dd2cbe6d0e73f894f2eeff91f | |
| ToppCell | ILEUM-inflamed-(6)_ILC3|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.85e-05 | 195 | 81 | 5 | c6968da7d2b60c2163e1ff0ffa41340e1ec1d2ed | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-05 | 196 | 81 | 5 | ad1838dabd043cb140260843e3527d8c7d58850e | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-05 | 196 | 81 | 5 | cbc15c0769016fe9972445169029bd8d14a7e6ef | |
| ToppCell | ILEUM-non-inflamed-(6)_ILC|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.99e-05 | 197 | 81 | 5 | 76a233eb9611d24b9bb9f4359c26606332a3c29e | |
| ToppCell | facs-Heart-LA-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-05 | 197 | 81 | 5 | 2a91738cb6d7588869dd00deeea0cbbc2d6aa34d | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-05 | 198 | 81 | 5 | 0dc7d59a07428a7b7e8bdc81f0e2417dd4ce3cf2 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Early_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.14e-05 | 199 | 81 | 5 | d67f5ae05daf942fb79f5b962021f37f4e275f4d | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.22e-05 | 200 | 81 | 5 | a9cdddc4e985dae59521e557479c24fcc2ac727d | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary-EC_aerocyte_capillary_L.2.0.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.22e-05 | 200 | 81 | 5 | 3767abc75176779198505ebc6967d55ce322d9fe | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6--L3-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.22e-05 | 200 | 81 | 5 | 33b9199e0dfc267e2cea20b82d1c167f8adcc635 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.22e-05 | 200 | 81 | 5 | 347a510755374c6a66acee326565dfc447993f18 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.22e-05 | 200 | 81 | 5 | 9719fabddc34051949468a7520289e3c750de4f8 | |
| ToppCell | TCGA-Blood_and_Bone_Marrow-Primary_Blood_Derived_Cancer_-_Peripheral_Blood-Leukemia-Acute_Myeloid_Leukemia-6|TCGA-Blood_and_Bone_Marrow / Sample_Type by Project: Shred V9 | 8.01e-05 | 125 | 81 | 4 | dd59d6ca4d36f9453eb1b1f260fab36c5d641cb2 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-HSC/MPP_and_pro-MEP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.14e-04 | 137 | 81 | 4 | 0bb5cccc31e7c44d44a2db3f59b68f9a81503151 | |
| ToppCell | Control-Fibroblasts-Mesothelial_FB|Control / group, cell type (main and fine annotations) | 1.21e-04 | 139 | 81 | 4 | e769beb031b262dd92c9605b07dbf3c29fb82520 | |
| ToppCell | COVID-19_Mild-Neu_2|World / 5 Neutrophil clusters in COVID-19 patients | 1.24e-04 | 140 | 81 | 4 | b1429028c52f84127b894b93b55961badcd5246f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-04 | 141 | 81 | 4 | 091b5b72811db5fca2314f4a79d467566920e257 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-hematologic-hematopoietic_progenitor-hematopoietic_stem_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.35e-04 | 143 | 81 | 4 | 27e06327f96cb72bd111ea6ece6307e5ebb3a146 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-hematologic-hematopoietic_progenitor|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.35e-04 | 143 | 81 | 4 | 4edef95ae2a1ef4fc4b0d4fadf75bfc54b583932 | |
| ToppCell | Influenza_Severe-CD4+_T_naive|World / Disease group and Cell class | 1.58e-04 | 149 | 81 | 4 | ce6552063510aa3e0b9d6e5b531eea67410e7056 | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_AB-8|TCGA-Thymus / Sample_Type by Project: Shred V9 | 1.66e-04 | 151 | 81 | 4 | 5906562efd36fbcb91f96e0a0d3a8fe999ba1e79 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-MPP_myeloid|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.75e-04 | 153 | 81 | 4 | 9ff31b07f5bdbd4d0211eae2fb38d3f2830bb4d6 | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD4+_T_naive|World / disease group, cell group and cell class (v2) | 1.93e-04 | 157 | 81 | 4 | 23879e65a6acc33d9aad096cd23604a77b0ac9c2 | |
| ToppCell | Influenza_Severe-CD4+_T_naive|Influenza_Severe / Disease group and Cell class | 1.93e-04 | 157 | 81 | 4 | 287bdc4e455cd0160261a93d13538e0def49fcd4 | |
| ToppCell | severe_influenza-CD4+_T_naive|World / disease group, cell group and cell class (v2) | 1.97e-04 | 158 | 81 | 4 | 8ab3d8a9b7a1daa890d76dde1d6182af40b70021 | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-gdT|Leuk-UTI / Disease, Lineage and Cell Type | 1.97e-04 | 158 | 81 | 4 | c4b0af25608cee3d0d2b0193f5ff45d9dc87078b | |
| ToppCell | severe_influenza-CD4+_T_naive|severe_influenza / disease group, cell group and cell class (v2) | 1.97e-04 | 158 | 81 | 4 | ff3fa4bd06e01363429aec4bb587b95819bf0fc9 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-HSC/MPP_and_pro-CMP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.07e-04 | 160 | 81 | 4 | be46daf3b42591768c83062a3bb4820efbf88bec | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-HSC/MPP_and_pro-MEP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.28e-04 | 164 | 81 | 4 | 47355439e578d1b1a387fb4ee761162028abea4a | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-Klrb1a/b/c(-)_NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-04 | 165 | 81 | 4 | eeb58d4db64ad37dc6b441eab22b05c24862e1a9 | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_progenitors-Progenitor|lymph-node_spleen / Manually curated celltypes from each tissue | 2.33e-04 | 165 | 81 | 4 | 7b992843bd8ef92a7a76b1d681fa84efde6f5bdd | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-HSC/MPP_and_pro-MPP_myeloid|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.33e-04 | 165 | 81 | 4 | dc70e050465d1f05bb4115356dc978aa581149b5 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_D3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.44e-04 | 167 | 81 | 4 | 99db8871c62336bd215efb65e969783d2b6003b0 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-24m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-04 | 167 | 81 | 4 | 7f3224af9b30082b927a822b91f96e0c88151b4e | |
| ToppCell | 3'_v3-Lung-Lymphocytic_Invariant-Inducer-like-ILC3|Lung / Manually curated celltypes from each tissue | 2.44e-04 | 167 | 81 | 4 | 0614d077b47a87f726068615548d0b0a216627be | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.44e-04 | 167 | 81 | 4 | 805129f887078340b260aa136b0ba19f2bd6ea03 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-24m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-04 | 167 | 81 | 4 | a21a2b301d0a3d7a41e605f7a3c37548962a331d | |
| Computational | Developmental processes. | 8.54e-05 | 333 | 47 | 8 | MODULE_220 | |
| Disease | chronic granulomatous disease (implicated_via_orthology) | 1.91e-07 | 5 | 80 | 3 | DOID:3265 (implicated_via_orthology) | |
| Disease | rheumatoid arthritis (implicated_via_orthology) | 4.15e-06 | 12 | 80 | 3 | DOID:7148 (implicated_via_orthology) | |
| Disease | leukemia (implicated_via_orthology) | 1.80e-05 | 19 | 80 | 3 | DOID:1240 (implicated_via_orthology) | |
| Disease | sex interaction measurement, longitudinal BMI measurement | 3.22e-04 | 10 | 80 | 2 | EFO_0005937, EFO_0008343 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 3.23e-04 | 49 | 80 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | Sjogren's Syndrome | 5.55e-04 | 13 | 80 | 2 | C1527336 | |
| Disease | Sicca Syndrome | 5.55e-04 | 13 | 80 | 2 | C0086981 | |
| Disease | Burkitt Leukemia | 7.45e-04 | 15 | 80 | 2 | C4721444 | |
| Disease | African Burkitt's lymphoma | 7.45e-04 | 15 | 80 | 2 | C0343640 | |
| Disease | blood lead measurement | 7.76e-04 | 66 | 80 | 3 | EFO_0007040 | |
| Disease | Alpha ketoglutarate measurement | 8.50e-04 | 16 | 80 | 2 | EFO_0010457 | |
| Disease | Attention Deficit Disorder | 1.62e-03 | 22 | 80 | 2 | C0041671 | |
| Disease | Minimal Brain Dysfunction | 1.62e-03 | 22 | 80 | 2 | C1321905 | |
| Disease | nighttime rest measurement | 1.93e-03 | 24 | 80 | 2 | EFO_0007827 | |
| Disease | Attention deficit hyperactivity disorder | 1.93e-03 | 24 | 80 | 2 | C1263846 | |
| Disease | Albuminuria | 1.93e-03 | 24 | 80 | 2 | C0001925 | |
| Disease | migraine disorder, diastolic blood pressure | 2.09e-03 | 25 | 80 | 2 | EFO_0006336, MONDO_0005277 | |
| Disease | Left Ventricular Hypertrophy | 2.09e-03 | 25 | 80 | 2 | C0149721 | |
| Disease | neurotic disorder | 2.64e-03 | 101 | 80 | 3 | EFO_0004257 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DQAIRDRFSRLRYQS | 536 | Q9H0X4 | |
| FRRRRAREAYTLQAT | 1341 | Q8TER5 | |
| ERRRLKESFENYRRK | 491 | Q9H257 | |
| SSSRYRENRSRDERK | 131 | Q5T8P6 | |
| ERERQHKQGRYSSRR | 261 | Q96EV2 | |
| ASLASRREQKREQYR | 616 | O60271 | |
| ERCRRRDTEQRRSYQ | 641 | Q5T5X7 | |
| NENYKSLVRRSYRRR | 476 | Q9Y618 | |
| LRSRFLDARRKRRNF | 226 | P40424 | |
| ANRRRFLLDTNKSRF | 186 | Q14566 | |
| EKEFHFNRYLTRRRR | 171 | Q00444 | |
| EKEFHFNRYLTRRRR | 171 | P31267 | |
| RQRTLDRLRTFKQRY | 676 | Q8N9B5 | |
| ANRRKEFINSLRLYR | 381 | P78333 | |
| DKNVRRRFRASNYQS | 96 | Q9Y6A4 | |
| FKRRFLAARALRSFR | 16 | Q9NVL1 | |
| RNRSRLKKDYDDFRR | 831 | Q5HYC2 | |
| VFRRRRNQDVRSRYK | 696 | O15075 | |
| ERERRRTQRYFMEAN | 806 | Q6ZWH5 | |
| LRRGFFNLNRSSKRE | 41 | Q92614 | |
| RKRLSQDAYRRNSVR | 316 | P14598 | |
| EKEFHFNRYLTRRRR | 211 | P20719 | |
| RARRAAAYNLEERRR | 556 | O14511 | |
| SYLERKRRNDQRSRF | 281 | P12525 | |
| RAAAQRFYGKRSRAE | 331 | Q9Y546 | |
| RRFRQQRYLSAPERE | 101 | O15522 | |
| FDRYFRSRTLANNRR | 341 | O00222 | |
| RREFAKFQSERSRAR | 751 | P18084 | |
| SRKRLSQDAYRRNSV | 316 | A6NI72 | |
| SRKRLSQDAYRRNSV | 291 | A8MVU1 | |
| KEFHFNRYLTRRRRI | 211 | P09067 | |
| KEFHFNRYLTRRRRI | 171 | P09016 | |
| YSEEESRRVRRNKRS | 146 | Q92838 | |
| REAYRRRTAAFQQDL | 56 | Q96BQ5 | |
| SNLLYQFRMNFRRRR | 211 | Q8TB45 | |
| KSISSRRRYNRDLEQ | 181 | P36894 | |
| LSREQSRRSYDDQLR | 86 | Q9NNZ3 | |
| RRQSFASLALRKRYS | 1456 | Q12955 | |
| DGFLRRKQRRNRTTF | 26 | A6NNA5 | |
| ERERRLRYKTFSREQ | 91 | Q5TF58 | |
| YQLCNNRKSFRLRRR | 216 | O43736 | |
| SNKYRAKADRRRQRS | 381 | Q12894 | |
| KFVRRNLSFRFARRN | 641 | Q7KZI7 | |
| YAVRRIRDAFRENKN | 31 | Q9HD34 | |
| REAARRRQRQYERSE | 411 | Q9NQR7 | |
| RRTAEYFPTKNRQRR | 191 | Q5T4B2 | |
| YSSERRAREREKERQ | 446 | Q9UPN6 | |
| EKEFHFNRYLTRRRR | 231 | Q00056 | |
| EKEFHFNRYLTRRRR | 146 | P31268 | |
| KTREFRERQARERDY | 1066 | Q8TEW0 | |
| LRRSRDDADRRYQSR | 761 | Q5BJF6 | |
| RYANARDRNQRRLGD | 236 | Q9ULK6 | |
| RRSFTTEKRNRNLLY | 31 | Q9NP81 | |
| ERMRNSRDRLLNRYR | 31 | Q86UA6 | |
| RNRIDTRQRRMNARY | 836 | O95425 | |
| KQYRRLARENRTDSA | 8061 | Q8NF91 | |
| EQFRRITYRDRNQRK | 886 | Q8NE09 | |
| RRNELKRSFFALRDQ | 366 | P01106 | |
| IRKFYTEFDRRNNRI | 386 | P00797 | |
| EFRARLVYDNNRSNR | 766 | P98174 | |
| LRANIERFNARRYDR | 771 | Q5VSL9 | |
| EAFYARARAKRNSRQ | 1371 | Q9C0D5 | |
| RSDYFRARASRDVLR | 161 | O94819 | |
| YCSRRQRRLRKTLNF | 86 | Q9UHB9 | |
| RRRDKFRRERSDYDR | 11 | Q9BXP5 | |
| RSERRKYGRDFLLRF | 501 | Q9UNK9 | |
| RLSLRRENYLSERRF | 501 | Q9UPV9 | |
| QRTTYDRRSSQERKF | 521 | Q86UC2 | |
| RRVSENKRRYTRDGF | 221 | P56180 | |
| LSTIKQRLENRFYRR | 1206 | Q8WWQ0 | |
| QLAENTRYFRRRLKE | 441 | O15270 | |
| RFDYTNERALRRTLQ | 921 | P24928 | |
| RREKERRYTNSSADN | 16 | Q9P273 | |
| EQEKRNSRLRDYRSL | 396 | Q8TC07 | |
| VYRFATDRNDFRRNL | 31 | Q96B49 | |
| NSRDRRRNPRRFQYR | 231 | Q9H9P5 | |
| ERRPRDDRAQSYRDK | 1736 | P49750 | |
| FQFSDYRIQRLKRER | 316 | Q53FD0 | |
| RAYRRSQRASFKRAR | 236 | Q9UKP6 | |
| RSRSRNRDRYYLRNN | 681 | Q9NS56 | |
| NIRDSFQKVTLRRYR | 26 | Q03924 | |
| RRNLSYTRELSRQRF | 41 | Q6R2W3 | |
| RDYKRRRQSYRAKNV | 216 | Q6IEG0 |